QT
AZN icon

Quantamental Technologies’s AstraZeneca AZN Stock Holding History

Quantamental Technologies’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,258
Closed -$357K – 459
2022
Q3 		$357K Buy
+3,258
New +$413K 0.14% 262
2021
Q1 		– Sell
-5,615
Closed -$561K – 84
2020
Q4 		$561K Buy
+5,615
New +$595K 1.75% 9
2020
Q1 		– Sell
-8,036
Closed -$801K – 133
2019
Q4 		$801K Buy
8,036
+5,196
+183% +$489K 0.41% 56
2019
Q3 		$253K Buy
+2,840
New +$246K 0.08% 410
2019
Q2 		– Sell
-3,232
Closed -$261K – 1464
2019
Q1 		$261K Buy
+3,232
New +$255K 0.12% 283

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Quantamental Technologies's AZN Position: Q4 2022 in Review

Quantamental Technologies sold out of AstraZeneca (AZN) in Q4 2022, closing a stake of 3,258 shares — an estimated $357K sold.

Quantamental Technologies first reported a position in AZN in Q1 2019 and held it in 5 quarters. The position peaked at $801K in Q4 2019. 1,062 funds tracked by Wall St. Rank hold AZN as of Q4 2022.

  • Quantamental Technologies reported no remaining AstraZeneca position as of Q4 2022 after selling out during the quarter.
  • Quantamental Technologies sold 3,258 AstraZeneca shares in Q4 2022, an estimated $357K.
  • Quantamental Technologies first reported a position in AstraZeneca in Q1 2019 and held it in 5 quarters.
  • Quantamental Technologies's AstraZeneca position peaked at $801K in Q4 2019.
  • 1,062 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2022.

Based on Quantamental Technologies's 13F filing for Q4 2022, filed 14 Feb 2023.